TrialNet meeting "From disease heterogeneity to patient endotypes in T1D"
In early January, Noel attended a workshop coordinated by TrialNet which was held in Tampa, Florida. The intense discussions were extremely productive and designed to improve the ways that type 1 diabetes is classified, by focussing on the underlying causes of the disease. Noel presented the Ibex team’s work suggesting that the involvement of the immune system in beta cell death may differ in very young children with type 1 diabetes, co
mpared to those who are older.